MihaelHPolymeropoulosMD

Psychosomatic Medicine

Physician

Are you Dr. Polymeropoulos?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Mihael Polymeropoulos, MD is a psychiatrist in Potomac, Maryland. He is currently licensed to practice medicine in Maryland and District of Columbia.

Clinical Center at the National Institutes of HealthFellowship, Psychosomatic Medicine, 1988 - 1989
Saint Elizabeths Hospital-DC Department of Behavioral HealthResidency, Psychiatry, 1985 - 1988
University of Patras School of MedicineClass of 1983

PubMed

1 citations
Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study.
Rosarelis Torres, Emily L Czeisler, Sean R Chadwick, Stephen M Stahl, Sandra P Smieszek
The Journal of Clinical Psychiatry. 2024-01-15
Corrigendum to “Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients” [Cytokine 148 (2021) 15...
Sandra P. Smieszek, Bartlomiej P Przychodzen, Vasilios Polymeropoulos, Bushra Mina, Christos Polymeropoulos
Cytokine. 2022-01-01
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.
Christos M Polymeropoulos, Vasilios M Polymeropoulos, Emily L Czeisler, Michaela A Fisher, Sandra P Smieszek
Frontiers in Neurology. 2022-01-01

Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in GastroparesisFebruary 3rd, 2022
Vanda Pharmaceuticals Reports Second Quarter 2021 Financial ResultsJuly 28th, 2021
Hedge Fund Manager Stands to Profit on ‘Flip’ of Taxpayer-Funded Coronavirus DrugJune 11th, 2020
Join now to see all